[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350566-105":59,"doc-detail-350566-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","rising-prevalence-of-venous-thromboembolism-in-gastrointestinal-cancers-a-nationwide-analysis-of-205-million-hospitalizations-2016-2022","Rising prevalence of venous thromboembolism in gastrointestinal cancers - a nationwide analysis of 205 million hospitalizations, 2016-2022","","Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, remains a major complication in malignancy, yet subtype-wide prevalence data across gastrointestinal cancers are limited. A cross-sectional nationwide analysis used the National Inpatient Sample (2016–2022) covering 205,075,197 adult hospitalizations to quantify DVT, PE, and VTE prevalence and temporal trends across gastrointestinal cancer subtypes. Results report higher overall VTE prevalence, rising trends over time, and increased inpatient death risk associated with VTE.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rising-prevalence-of-venous-thromboembolism-in-gastrointestinal-cancers-a-nationwide-analysis-of-205-million-hospitalizations-2016-2022/350566/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rising-prevalence-of-venous-thromboembolism-in-gastrointestinal-cancers-a-nationwide-analysis-of-205-million-hospitalizations-2016-2022/350566.png","ImageObject",300,407,{"name":92,"@type":93},"Blitz","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What were the study aims regarding VTE in gastrointestinal cancers?","Question",{"text":113,"@type":114},"The study quantified the prevalence of lower-extremity DVT, PE, and overall VTE in gastrointestinal cancer hospitalizations and assessed prevalence trends from 2016 to 2022.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the nationwide analysis conducted?",{"text":118,"@type":114},"It used the National Inpatient Sample (NIS) database from 2016 to 2022 and performed a cross-sectional analysis of 205,075,197 adult hospitalizations.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the results show about VTE prevalence and trends?",{"text":122,"@type":114},"VTE prevalence was higher in gastrointestinal cancer hospitalizations than in all hospitalizations, with a statistically significant rising trend for gastrointestinal cancers over time, including changes occurring before the COVID-19 pandemic.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},350566,1790125943,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Original Article  \nRising prevalence of venous thromboembolism in gastrointestinal cancers: a nationwide analysis of 205 million hospitalizations, 2016–2022  \nKuldeepsinh Pradipkumar Atodaria1^, Arpeet Patel2^, Niharika Kottapalli1, Pratap Tetali1^, Sabah Iqbal1, Samyak Dhruv3, Tarun Parvataneni4^, Steven J. Cohen5, Ammar Ashfaq6  \n1Department of Hematology and Medical Oncology, Tower Health Reading Hospital, West Reading, PA, USA; 2Drexel University College of Medicine, Philadelphia, PA, USA; 3Giesinger Wyoming Valley Medical Center, Wilkes-Barre, PA, USA; 4Aiken Regional Medical Center, Aiken, SC, USA; 5Sidney Kimmel Comprehensive Cancer Center at Jefferson, Philadelphia, PA, USA; 6Sutter Medical Center, Sacramento, CA, USA Contributions: (I) Conception and design: All authors; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \nCorrespondence to: Kuldeepsinh Pradipkumar Atodaria, MD. Chief Fellow, Department of Hematology and Medical Oncology, Tower Health Reading  \nHospital, 420 S 5th Ave., West Reading, PA 19611, [USA. Email: kuldeep.atodaria@yahoo.com](USA. Email: kuldeep.atodaria@yahoo.com).  \nBackground: Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is a well-recognized complication of malignancy, yet comprehensive data on  \nVTE prevalence across all gastrointestinal cancer (GIC) subtypes are lacking.  \nMethods: Using the National Inpatient Sample (NIS) database from 2016 to 2022, we performed a crosssectional analysis of 205,075,197 adult hospitalizations to quantify the prevalence and temporal trends of DVT, PE and VTE in GIC hospitalizations, and calculated the relative risk (RR) of VTE and inpatient death (IPD) in GICs compared with all hospitalizations. GICs included malignant neoplasms of the esophagus, stomach, small intestine, colon, rectosigmoid junction, rectum, anus and anal canal, liver, intrahepatic bile  \nduct, gallbladder, biliary tract, pancreas, and neuroendocrine tumors.  \nResults: Of 3,663,570 GIC hospitalizations (1.78%), VTE was present in 197,355(5.39%), compared with 2.21% in all hospitalizations [RR =2.44; 95% confidence interval (CI): 2.43–2.45] . Pancreatic cancer had the highest VTE prevalence (8.44%), followed by gallbladder (7.05%) and stomach cancer (6.79%) . A statistically significant rising trend in VTE prevalence was observed for GICs (Cochran-Armitage P\u003C0.001), notably beginning before the coronavirus disease 2019 (COVID-19) pandemic, whereas VTE in all hospitalizations remained stable at 2% from 2016 to 2019 before rising sharply in 2020. IPD with VTE in GICs was 11.5%, compared to 7.4% for all hospitalizations with VTE (RR =1.55; 95% CI: 1.53–1.57) . VTEin GICs was associated with a 91% higher risk of IPD compared to GIC hospitalizations without VTE (RR  \n=1.91; 95% CI: 1.89–1.94) .  \nConclusions: These findings highlight the elevated and rising VTE burden across GIC subtypes and  \nunderscore the importance of VTE risk assessment and prophylaxis in hospitalized GIC patients.  \nKeywords: Venous thromboembolism; gastrointestinal cancers; deep vein thrombosis; pulmonary embolism  \nSubmitted Dec 02, 2025. Accepted for publication Apr 02, 2026. Published online May 15, 2026.  \ndoi: 10.21037/jgo-2025-1-999  \nView this article at: [https://dx.doi.org/10.21037/jgo-2025-1-999](https://dx.doi.org/10.21037/jgo-2025-1-999)  \n^ ORCID: Kuldeepsinh Pradipkumar Atodaria, 0000-0002-1786-920X; Arpeet Patel, 0009-0008-5899-4243; Pratap Tetali, 0009-0002- 8058-5792; Tarun Parvataneni, 0000-0001-5037-616X.  \n© AME Publishing Company. J Gastrointest Oncol 2026;17(3):145 | [https://dx.doi.org/10.21037/jgo-2025-1-999](https://dx.doi.org/10.21037/jgo-2025-1-999)  \nPage 2 of 12 Atodaria et al. Venous thromboembolism in","cbCainV5lErKYMq8","https://ap.wps.com/l/cbCainV5lErKYMq8","pdf",673111,"English","# Introduction\n## Background\n## Study approach and objective\n# Methods\n## Data source and design\n## Cancer subtypes and outcomes\n# Results\n## VTE prevalence by subtype\n## Temporal trends\n## Inpatient death association\n# Conclusions\n## Clinical implications\n# Keywords","[{\"question\":\"What were the study aims regarding VTE in gastrointestinal cancers?\",\"answer\":\"The study quantified the prevalence of lower-extremity DVT, PE, and overall VTE in gastrointestinal cancer hospitalizations and assessed prevalence trends from 2016 to 2022.\"},{\"question\":\"How was the nationwide analysis conducted?\",\"answer\":\"It used the National Inpatient Sample (NIS) database from 2016 to 2022 and performed a cross-sectional analysis of 205,075,197 adult hospitalizations.\"},{\"question\":\"What did the results show about VTE prevalence and trends?\",\"answer\":\"VTE prevalence was higher in gastrointestinal cancer hospitalizations than in all hospitalizations, with a statistically significant rising trend for gastrointestinal cancers over time, including changes occurring before the COVID-19 pandemic.\"}]","Rising prevalence of venous thromboembolism in gastrointestinal cancers - a nationwide analysis of 205 million hospitalizations, 2016-2022 | PDF",1790089647,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb21bd5f1c170adcedfe50c8ebb10881.webp",983,1287,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93097e37147d4945984bc6aaf860d6bf.webp",982,1286,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d762432002bba0bd5a46a65ded76cf13.webp",981,1284,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97485d8a0d0bc5d4191374b34178b9c7.webp",980,641]